Physician profile
Robert Rahmani
NPI 1356582308
$32,951.47
in general payments reported to CMS, 2019-2025
45 companies · $6,813 in 2025
The $6,813 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,232 · 2020: $2,257 · 2021: $5,723 · 2022: $9,170 · 2023: $2,325 · 2024: $3,432 · 2025: $6,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,498 · Long Term Medical Supply Or Device Loan: $3,973 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,497.63 |
| Long Term Medical Supply Or Device Loan | $3,973.33 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $6,676.00 | 2022 | |
| Angiodynamics, INC. | $4,398.04 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Welch Allyn | $3,476.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,604.40 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $1,393.98 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $1,376.66 | 2021-2025 | Linq II, Micra |
| Janssen Pharmaceuticals, INC | $1,319.60 | 2019-2022 | |
| Boston Scientific Corporation | $1,236.28 | 2019-2025 | Varithena Administration Pack, Watchman Flx, Watchman Access System |
| Pfizer INC. | $1,153.10 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,033.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,018.56 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $978.45 | 2021-2025 | Verquvo, Capvaxive, Steglatro |
| Abbott Laboratories | $761.57 | 2019-2024 | Jot Dx |
| Amgen INC. | $669.78 | 2019-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $598.51 | 2023-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $581.14 | 2019-2025 | Lifevest |
| Smith+Nephew, INC. | $575.23 | 2023-2025 | Grafix Pl, Grafix, Oasis |
| Novo Nordisk INC | $431.12 | 2021-2025 | Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $419.11 | 2019-2020 | |
| Abbvie INC. | $341.18 | 2021-2025 | |
| Edwards Lifesciences Corporation | $329.15 | 2020-2025 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $316.57 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $259.12 | 2021-2025 | |
| Lundbeck LLC | $207.42 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $202.30 | 2019-2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $190.84 | 2023-2024 | Inpefa |
| Althera Pharmaceuticals LLC | $173.70 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $157.18 | 2024-2025 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $147.36 | 2019-2021 | |
| Tactile Systems Technology INC | $130.39 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Allergan, INC. | $109.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $103.86 | 2025 | |
| Biocompatibles, INC. | $95.17 | 2019 | |
| Bardy Diagnostics, INC. | $65.55 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $60.95 | 2020-2022 | |
| Inspire Medical Systems, INC. | $49.96 | 2024-2025 | Inspire |
| Gilead Sciences, INC. | $49.04 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $45.02 | 2022 | |
| Lilly USA, LLC | $42.07 | 2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $39.29 | 2024-2025 | Trelegy Ellipta |
| Becton, Dickinson and Company | $30.96 | 2025 | Venclose Maven Catheter |
| Infobionic, INC | $30.73 | 2019-2022 | |
| Astellas Pharma US INC | $29.55 | 2019 | |
| Eisai INC. | $29.34 | 2025 | |
| Genentech USA, INC. | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rahmani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.